Modified Skindex-16 scores
Normalized overall Skindex-17 scores ranged from 0 to 61 with the highest scores reported in the first 2 days after infusion. Scores decreased thereafter with only four participants reporting scores beyond Day 14. The highest normalized domain (symptoms) score was 75 reported by a cohort 2 participant on Day 2. The normalized domain and overall Skindex-16 scores for the first 7 days by cohort and all cohorts combined are provided (Table S2).For a between-cohort comparison of normalized overall Skindex scores by day, the only significant difference was noted on Day 3 between cohorts 1 and 2 (